FEAM:NSD-5E Advanced Materials Inc (USD)

COMMON STOCK | Specialty Chemicals |

Last Closing

USD 4.42

Change

0.00 (0.00)%

Market Cap

USD 0.08B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-10 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

+1.76 (+0.39%)

USD 208.95B
BCPC Balchem Corporation

+1.00 (+0.61%)

USD 5.28B
WDFC WD-40 Company

+5.39 (+2.33%)

USD 3.04B
HWKN Hawkins Inc

-1.92 (-1.60%)

USD 2.63B
IOSP Innospec Inc

+0.19 (+0.21%)

USD 2.27B
CLMT Calumet Specialty Products Par..

+0.80 (+6.49%)

USD 1.07B
GEVO Gevo Inc

+0.03 (+2.59%)

USD 0.29B
HDSN Hudson Technologies Inc

+0.26 (+3.49%)

USD 0.24B
LWLG Lightwave Logic Inc

+0.05 (+4.95%)

USD 0.11B
NTIC Northern Technologies

+0.08 (+1.10%)

USD 0.07B

ETFs Containing FEAM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -69.97% 11% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -69.97% 11% F 5% F
Trailing 12 Months  
Capital Gain -86.56% 21% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.56% 21% F 5% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -52.15% 5% F 1% F
Dividend Return -52.15% 5% F 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 36.62% 68% D+ 49% F
Risk Adjusted Return -142.42% 5% F 1% F
Market Capitalization 0.08B 50% F 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector